Wednesday, May 17, 2017

BRIEF-FDA grants Bayer priority review for investigational compound Copanlisib

* FDA grants Bayer priority review for investigational compound Copanlisib in Follicular Lymphoma

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)